{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260824589114/en/Spruce-Biosciences-Announces-Positive-Pre-BLA-Meetings-with-FDA-and-Confirms-BLA-Submission-for-TA-ERT-on-Track-for-Q4-2026", "message": "News view counter 898623 successfully enlarged"}